The association of RCAS1 serum concentration with the reversibility or irreversibility of the process of immune cytotoxic activity restriction during normal menstrual cycle, cancer relapse, and surgical treatment for various types of squamous cell carcinomas and adenocarcinomas

American Journal of Reproductive Immunology

Volumn 59, Issue 3, 2008, Pages 266-275

  Dutsch Wicherek, Magda ^a   Wicherek, Lukasz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Endometrium; Immune tolerance; Placental abruption; Review; Spontaneous labor; Tubal rupture

Indexed keywords

PROTEIN RCAS1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CARCINOGENESIS; CELL CYCLE PHASE; CELL PROLIFERATION; CELL SECRETION; CELLULAR IMMUNITY; CONTROLLED STUDY; DECIDUALIZATION; FEMALE; HUMAN; IMMUNOCYTOTOXICITY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; ADULT; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNE TOLERANCE; MENSTRUAL CYCLE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PREGNANCY; TUMOR ESCAPE; UTERINE NEOPLASMS;

EID: 39149141375     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00575.x     Document Type: Article

References (70)

1. Hahn WC: Immortalization and transformation of human cells. Mol Cel 2002; 13:351-361.
2. Hahn WC, Weinberg RA: Modelling the molecular circuitry of cancer. Nat Rev Cancer 2002; 2:331-341.
3. Boehm JS, Hahn WC: UnderPtanding transformation: progress and gaps. Curr Opin Genet Dev 2005; 15:13-17.
4. Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A, Marquez RT, Auersperg N, Yu Y, Hahn WC, Mills GB, Bast RC: A genetically defined model for human ovarian cancer. Cancer Res 2004; 64:1655-1663.
5. Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL: Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. Clin Cancer Res 1999; 5:1263-1273.
6. Wilczynski JR: Cancer and pregnancy share similar mechanisms of immunological escape. Chemotherapy 2006; 52:107-110.
7. Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999; 5:938-942.
8. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol 2005; 97:772-779.
9. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Invasive potency related to RCAS1 expression in uterine cervical cancer. Gynecol Oncol 2005; 99:189-198.
10. Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Clinical significance of RCAS1 as a biomarker of uterine cancer. Gynecol Oncol 2006; 103:924-931.
11. Watanabe H, Enjoji M, Nakashima M, Noguchi K, Kinukawa N, Sugimoto R, Kotoh K, Nakamuta M, Nawata H, Watanabe T: Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma. J.Hepatol 2003; 39:559-563.
12. Dutsch-Wicherek M, Wicherek L, Mak P, Skladzien J: Assessment of RCAS1 expression in selected head and neck diseases. Otorynolaryngologia 2004; 3:25-28.
13. Popiela TJ, Rudnicka-Sosin L, Dutsch-Wicherek M, Klimek M, Basta P, Galazka K, Wicherek L: The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity. Neuro Endocrinol Lett 2006;27:786-794.
14. Akahira JI, Aoki M, Suzuki T, Moriya T, Niikura H, Ito K, Inoue S, Okamura K, Sasano H, Yaegashi N: Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. Br J Cancer 2004; 90:2197-2202.
15. Ito Y, Yoshida H, Nakano K, Kobayashi K, Yokozawa T, Hirai K, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A: Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma. Oncology 2003; 64:83-89.
16. Wicherek L, Popiela TJ, Galazka K, Dutsch-Wicherek M, Oplawski M, Basta A, Klimek M: Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and the endometrium according to menstrual cycle changes. Gynecol Oncol 2005; 99:622-630.
17. Aoki T, Inoue S, Imamura H, Fukushima J, Takahashi S, Urano T, Hasegawa K, Ogushi T, Ouchi Y, Makuuchi M: EBAG9/RCAS1 expression in hepatocellular carcinoma: Correlation with tumour dedifferentiation and proliferation. Eur J Cancer 2003; 39:1552-1561.
18. Ozkan H, Akar T, Koklu S, Coban S: Significance of serum receptor-binding cancer antigen (RCAS1) in pancreatic cancer and benign pancreatobiliary diseases. Pancreatology 2006; 6:268-272.
19. Nakakubo Y, Hida Y, Miyamoto M, Hashida H, Oshikiri T, Kato K, Suzuoki M, Hiraoka K, Ito T, Morikawa T, Okushiba S, Kondo S, Katoh H: The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus. Cancer Lett 2002; 177:101-105.
20. Rousseau J, Tetu B, Caron D, Malenfant P, Cattaruzzi P, Audette M, Doillon C, Tremblay JP, Guerette B: RCAS1 is associated with ductal breast cancer progression. Biochem Biophys Res Commun 2002; 293:1544-1549.
21. Leelawat K, Watanabe T, Nakajima M, Tujinda S, Suthipintawong C, Leardkamolkarn V: Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer. J.Clin Pathol 2003; 56:764-768.
22. Nakamura Y, Yamazaki K, Oizumi S, Nakashima M, Watanabe T, Dosaka-Akita H, Nishimura M: Expression of RCAS1 in humAn gastric carcinoma: a potential mechanism of immune escape. Cancer Sci 2004; 95:260-265.
23. Enjoji M, Nakashima M, Yamaguchi K, Kotoh K, Nakamuta M: Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas. J.Gastroenterol Hepatol 2005; 20:1143-1148.
24. Kato H, Nakajima M, Masuda N, Faried A, Sohda M, Fukai Y, Miyazaki T, Fukuchi M, Tsukada K, Kuwano H: Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis. J.Surg Oncol 2005; 90:89-94.
25. Akashi T, Oimomi H, Nishiyama K, Nakashima M, Arita Y, Sumii T, Kimura T, Ito T, Nawata H, Watanabe T: Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer. Pancreas 2003; 26:49-55.
26. Yamaguchi K, Enjoji M, Nakashima M, Nakamuta M, Watanabe T, Tanaka M: Novel serum tumor marker, RCAS1, in pancreatic diseases. World J Gastroenterol 2005; 11:5199-5202.
27. Enjoji M, Yamaguchi K, Nakashima M, Ohta S, Kotoh K, Fukushima M, Kuniyoshi M, Tanaka M, Nakamuta M, Watanabe T, Nawata H: Serum levels of soluble molecules associated with evasion of immune surveillance: A study in biliary disease. Liver Int 2004; 24:330-334.
28. Dutsch-Wicherek M, Popiela TJ, Wicherek L, Modrzejewski M, Tomaszewska R, Składzień J: RCAS1 expression in laryngeal and pharyngeal cancer with local lymph node metastasis. in 5th EUFOS 2004, S Papaspyrou (ed). Rodos, Medimond S.r.l, 2004, pp 345-348.
29. Sonoda K, Miyamoto S, Nakashima M, Wake N: Biological role of the unique molecule rcas1: A bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis. Front Biosci 2008; 13:1106-1116.
30. Iwasaki T, Nakashima M, Watanabe T, Yamamoto S, Inoue Y, Yamanaka H, Matsumura A, Iuchi K, Mori T, Okada M: Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer 2000; 89:488-493.
31. Nakabayashi H, Nakashima M, Hara M, Toyonaga S, Yamada SM, Park KC, Shimizu K: Clinico-pathological significance of RCAS1 expression in gliomas: A potential mechanism of tumor immune escape. Cancer Lett 2007; 246:182-189.
32. Tsujitani S, Saito H, Oka S, Sakamoto T, Kanaji S, Tatebe S, Ikeguchi M: Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma. Dig Dis Sci 2007; 52:549-554.
33. Toyoshima T, Nakamura S, Kumamaru W, Kawamura E, Ishibashi H, Hayashida JN, Moriyama M, Ohyama Y, Sasaki M, Shirasuna K: Expression of tumor-associated antigen RCAS1 and its possible involvement in immune evasion in oral squamous cell carcinoma. J.Oral Pathol Med 2006; 35:361-368.
34. Fukuda M, Tanaka A, Hamao A, Suzuki S, Kusama K, Sakashita H: Expression of RCAS1 and its function in human squamous cell carcinoma of the oral cavity. Oncol Rep 2004; 12:259-267.
35. Enjoji M, Nakashima M, Nishi H, Choi I, Oimomi H, Sugimoto R, Kotoh K, Taguchi K, Nakamuta M, Nawata H, Watanabe T: The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of biliary tract. J.Hepatol 2002; 36:786-792.
36. Suzuki T, Inoue S, Kawabata W, Akahira J, Moriya T, Tsuchiya F, Ogawa S, Muramatsu M, Sasano H: EBAG9/RCASA in human breast carcinoma: a possible factor in endocrine-immune interactions. Br J Cancer 2001; 85:1731-1737.
37. Okada K, Nakashima M, Komuta K, Hashimoto S, Okudaira S, Baba N, Hishikawa Y, Koji T, Kanematsu T, Watanabe T: Expression of tumor-associated membrane antigen, RCAS1, in human colorectal carcinomas and possible role in apoptosis of tumor-infiltrating lymphocytes. Mod Pathol 2003; 16:679-685.
38. Fukuda K, Tsujitani S, Maeta Y, Yamaguchi K, Ikeguchi M, Kaibara N: The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma. Gastric Cancer 2002; 5:220-227.
39. Ohshima K, Nakashima M, Sonoda K, Kikuchi M, Watanabe T: Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: The possible role in immune privilege. Clin Exp Immunol 2001; 123:481-486.
40. Wicherek L, Dutsch M, Mak P, Klimek M, Skladzien J, Dubin A: Comparative analysis of RCAS1 level in neoplasmsand placenta. Acta Biochim Pol 2003; 50:1187-1194.
41. Wicherek L, Dutsch-Wicherek M, Mak P, Klimek M: The role of RCAS1 and oxytocinase in immune tolerance during pregnancy. Fetal Diagn Ther 2005; 20:420-425.
42. Wicherek L, Klimek M, Dutsch-Wicherek M, Kolodziejski L, Skotniczny K: The molecular changes during placenta detachment. Eur J Obstet Gynecol Reprod Biol 2006; 125:171-175.
43. Wicherek L, Galazka K, Lazar A: RCAS1 Decidual Immunoreactivity During Placental Abruption: Immune Cell Presence and Activity. Am J Reprod Immunol 2007; 58:46-55.
44. Sonoda K, Nakashima M, Saito T, Amada S, Kamura T, Nalano H, Watanabe T: Establishment of a new human uterine cervical adenocarcinoma cell line, SiSo, and its reactivity to anti-cancer reagents. Int J Oncol 1995; 6:1099-1104.
45. Tskitishvili E, Komoto Y, Kinugasa Y, Kanagawa T, Song M, Mimura K, Tomimatsu T, Kimura T, Shimoya K: The human tumor-associated antigen RCAS1 in pregnancies complicated by preeclampsia. J.Reprod Immunol 2007; 77:100-108.
46. Wicherek L, Basta P, Galazka K, Mak P, Dancewicz L, Kalinka J: RCAS1 decidual immunoreactivity and RCAS1 serum level during cesarean section with respect to the progression of labor. Am J Reprod Immunol 2008; 59:152-158.
47. King A, Burrows T, Loke YW: Human uterine natural killer cells. Nat Immun 1996; 15:41-52.
48. Ordi J, Casals G, Ferrer B, Creus M, Guix C, Palacin A, Campo E, Balasch J: Uterine (CD56+) natural killer cells recrAitment: association with decidual reaction rather than embryo implantation. Am J Reprod Immunol 2006; 55:369-377.
49. Tabibzadeh S: Molecular control of the implantation window. Hum Reprod Update 1998; 4:465-471.
50. Chen WJ: Dendritic cells and CD4+CD25+ T regClatory cells: crosstalk between two professionals in immunity versus tolerance. Front Biosci 2006; 11:1360-1370.
51. Sharma S, Murphy SP, Barnea ER: Genes regulating implantation and fetal development: A focus on mouse knockout models. Front Biosci 2006; 11:2123-2137.
52. Garai J, Molnar V, Varga T, Koppan M, Torok A, Bodis J: Endometriosis: harmful survival of an ectopic tissue. Front Biosci 2006; 11:595-619.
53. Souza SS, Castro FA, Mendonca HC, Palma PV, Morais FR, Ferriani RA, Voltarelli JC: Influence of menstrual cycle on NK activity. J.Reprod Immunol 2001; 50: 151-159.
54. + T lymphocytes in normal pregnancies. Mol Hum Reprod 2002; 8:667-673.
55. Szekeres-Bartho J, Varga P, Pacsa AS: Immunologic factors contributing to the initiation of labor -lymphocyte reactivity in term labor and threatened preterm delivery. Am J Obstet Gynecol 1986; 155:108-112.
56. Abadia-Molina AC, Ruiz C, Montes MJ, King A, Loke YW, Olivares EG: Immune phenotype and cytotoxic activity of lymphocytes from human term decidua against trophoblast. J.Reprod Immunol 1996; 31:109-123.
57. Sindram-Trujillo AP, Scherjon SA, van Hulst-van Miert PP, Kanhai HH, Roelen DL, Claas FH: Comparison of decidual leukocytes following spontaneous vaginal delivery and elective cesarean section in uncomplicated human term pregnancy. J.Reprod Immunol 2004; 62:125-137.
58. Wilczynski JR, Tchorzewski H, Banasik M, Glowacka E, Wieczorek A, Lewkowicz P, Malinowski A, Szpakowski M, Wilczynski J: Lymphocyte subset distribution and cytokines secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 109:8-15.
59. Bachmayer N, Rafik-Hamad R, Liszka L, Bremme K, Sverremark-Ekstrom E: Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia. Am J Reprod Immunol 2006; 56:292-301.
60. Aagaard-Tillery KM, Stoddard GJ, Holmgren C, Lacoursiere DY, Fraser A, Mineau GP, Varner MW: Preeclampsia and subsequent risk of cancer in Utah. Am J Obstet Gynecol 2006; 195:691-699.
61. Wilczynski JR: Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia- the same basic mechanism. Hum Immunol 2006; 67:492-511.
62. Kawano Y, Kaku T, Sonoda K, Hirakawa T, Kobayashi H, Ohishi Y, Nakano H: Expression of RCAS1 in female genital organs. Int J Gynecol Pathol 2005; 24:330-334.
63. Wicherek L, Galazka K, Lazar A: The analysis of Metallothionein, RCAS1 immunoreactivity regarding immune cells concentration in endometrium and tubal mucosa in ectopic pregnancy during the course of tubal rupture. Gynecol Obstet Invest 2007; 65:52-61.
64. Wicherek L, Galazka K, Klimek M, Obrzut B: Cycle dependent RCAS1 expression with respect to the immune cells presence and activity. Neuro Endocinol Lett 2006; 27:645-650.
65. Fujieda S, Sunaga H, Tsuzuki H, Fan GK, Ito T, Sugimoto C, Saito H: Expression of Fas (CD95) ligand is correlated with IL-10 and granulocyte colony-stimulating factor expression in oral and oropharyngeal squamous cell carcinoma. Cancer Lett 2000; 161:73-81.
66. Ortiz-Sanchez E, Chavez-Olmos P, Pina-Sanchez P, Salcedo M, Garrido E: Expression of the costimulatory molecule CD86, but not CD80, in keratinocytes of normal cervical epithelium and human papillomavirus-16 positive low squamous intraepithelial lesions. Int J Gynecol Cancer 2007; 17:571-580.
67. Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM: Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma. Cancer Res 2005; 65:2921-2929.
68. Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM, Huang SC: Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J.Immunol 2001; 167:2972-2978.
69. Derre L, Corvaisier M, Pandolfino MC, Diez E, Jotereau F, Gervois N: Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implication for adoptive immunotherapy. J.Immunol 2002; 168:4864-4870.
70. Kopcow HD, Allan DS, Chen X, Rybalov B, Andzelm MM, Ge B, Strominger JL: Human decidual NK cells from immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA 2005; 102:15563-15568.